NO20080103L - Bioaktive peptider identifisert i encymatiske hydrolyzater av caseiner fra melk og fremgangsmater for fremskaffelse av disse - Google Patents

Bioaktive peptider identifisert i encymatiske hydrolyzater av caseiner fra melk og fremgangsmater for fremskaffelse av disse

Info

Publication number
NO20080103L
NO20080103L NO20080103A NO20080103A NO20080103L NO 20080103 L NO20080103 L NO 20080103L NO 20080103 A NO20080103 A NO 20080103A NO 20080103 A NO20080103 A NO 20080103A NO 20080103 L NO20080103 L NO 20080103L
Authority
NO
Norway
Prior art keywords
milk
caseins
bioactive
obtaining
methods
Prior art date
Application number
NO20080103A
Other languages
English (en)
Inventor
Isidra Recio Sanchez
Ana Quiros Del Bosque
Blanca Hernandez Ledesma
Jose Angel Gomez Ruiz
Marta Miguel Castro
Maria Lourdes Amigo Garrido
Ivan Lopez Exposito
Maria Mercedes Ramos Gonzalez
Amaya Aleixandre De Artinano
Original Assignee
Consejo Superior Investigacion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior Investigacion filed Critical Consejo Superior Investigacion
Publication of NO20080103L publication Critical patent/NO20080103L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732Casein
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00Working-up of proteins for foodstuffs
    • A23J3/30Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/341Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
    • A23J3/343Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
    • A23J3/344Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins of casein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06Tripeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/18Antioxidants, e.g. antiradicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/06Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Sammendrag Oppfinnelsen vedrører fremstillingen av bioaktive produkter som er avledet fra melkeproteiner i fremstillingen av bioaktive melkeprodukter som er avledet fra melkeproteiner, spesielt kaseiner. De 16 oppfinneriske peptidene kan bli fremskaffet kjemisk, bioteknologisk eller ved hjelp av enzymatisk behandling fra proteiner inneholdende de samme og gi opphav til peptider med antimikrobiell aktivitet, en in vitro angiotensinkonverterende enzyminhibitorisk aktivitet og/eller antihypertensiv aktivitet og/eller antioksidantaktivitet. Nevnte næringsmiddelprodukter er egnet for anvendelse i matvareindustrien og den fannasøytiske industrien, både i form av et hydrolysat eller bioaktive peptider.
NO20080103A 2005-06-08 2008-01-07 Bioaktive peptider identifisert i encymatiske hydrolyzater av caseiner fra melk og fremgangsmater for fremskaffelse av disse NO20080103L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200501373A ES2319475B1 (es) 2005-06-08 2005-06-08 Peptidos bioactivos identificados en hidrolizados enzimaticos de caseinas lacteas y procedimiento de obtencion.
PCT/ES2006/070079 WO2006131586A1 (es) 2005-06-08 2006-06-08 Péptidos bioactivos identificados en hidrolizados enzimáticos de caseínas lácteas y procedimiento de obtención

Publications (1)

Publication Number Publication Date
NO20080103L true NO20080103L (no) 2008-03-04

Family

ID=37498152

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080103A NO20080103L (no) 2005-06-08 2008-01-07 Bioaktive peptider identifisert i encymatiske hydrolyzater av caseiner fra melk og fremgangsmater for fremskaffelse av disse

Country Status (12)

Country Link
US (1) US8354502B2 (no)
EP (2) EP2495250A3 (no)
JP (1) JP2008545774A (no)
KR (1) KR101343904B1 (no)
CN (2) CN103254278B (no)
AU (1) AU2006256720A1 (no)
BR (1) BRPI0611729A2 (no)
CA (1) CA2611416C (no)
ES (1) ES2319475B1 (no)
MX (1) MX2007015528A (no)
NO (1) NO20080103L (no)
WO (1) WO2006131586A1 (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10331202A1 (de) 2003-07-10 2005-03-31 S.K. Enterprise Gmbh Verwendung von Molkenpermeat zur Behandlung des Metabolischen Syndroms
WO2007110296A1 (en) * 2006-03-24 2007-10-04 Unilever N.V. Healthy food product
DE102006036285A1 (de) * 2006-08-03 2008-02-07 "S.U.K." Beteiligungs Gmbh Fraktionen aus Molkepermeat und deren Verwendung zur Prävention und Therapie des Typ-2 Diabetes und des Metabolischen Syndroms
EP2253324A1 (en) * 2009-04-30 2010-11-24 Consejo Superior De Investigaciones Cientificas Use of a casein-derived peptide and compositions thereof as antihypertensive
US20120322726A1 (en) * 2010-02-24 2012-12-20 Morinaga Milk Industry Co., Ltd. Therapeutic agent for eating disorders
CN103232526B (zh) * 2012-12-12 2015-06-24 上海交通大学 一种生物活性多肽lplp及其制备和应用
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
CN103616454B (zh) * 2013-12-06 2015-06-03 贝因美婴童食品股份有限公司 一种定量检测人β-酪蛋白含量的方法以及试剂盒
CN104073539B (zh) * 2014-06-17 2017-03-29 黑龙江省乳品工业技术开发中心 一种牛乳β‑酪蛋白多元活性肽的制备方法及其应用
JP2017048124A (ja) * 2015-08-31 2017-03-09 森永乳業株式会社 アミノペプチダーゼa阻害剤
EP3170507B1 (en) 2015-11-20 2022-12-21 Consejo Superior de Investigaciones Científicas (CSIC) Antihypertensive peptides from olive oil
CN107337710A (zh) * 2017-07-26 2017-11-10 盐城卫生职业技术学院 一种抗高血压活性肽The‑The‑Pro及应用和药物组合物
CN107814838A (zh) * 2017-12-07 2018-03-20 浙江辉肽生命健康科技有限公司 一种生物活性多肽ypqrdmpiqaf及其制备方法和应用
CN107880106B (zh) * 2017-12-11 2020-06-16 浙江辉肽生命健康科技有限公司 一种生物活性多肽vpitptlnre及其制备方法和应用
KR102073824B1 (ko) * 2018-04-11 2020-02-05 강원대학교산학협력단 간 보호용 건강기능식품 및 이의 제조 방법
CN111606972B (zh) * 2019-01-30 2022-04-05 浙江省医学科学院 一种鳕鱼皮寡肽及其分离纯化和在制备ɑ-葡萄糖苷酶抑制剂及抗Ⅱ型糖尿病药物中的应用
CN110498833B (zh) * 2019-08-30 2021-01-15 华南理工大学 一种具有ace抑制作用的三肽及其应用
US11326176B2 (en) * 2019-11-22 2022-05-10 Mozza Foods, Inc. Recombinant micelle and method of in vivo assembly
CN111777665B (zh) * 2020-07-24 2022-07-05 北京林业大学 一种核桃粕抗氧化肽faw及其制备方法与应用
CN115505025A (zh) * 2022-11-10 2022-12-23 东北农业大学 一种基于老年人静态消化模型的乳清蛋白源抗氧化肽的筛选
CN116444608B (zh) * 2022-11-30 2024-06-25 内蒙古伊利实业集团股份有限公司 乳源活性肽dpsffake及其制备方法与应用
CN116444609B (zh) * 2022-11-30 2024-06-04 内蒙古伊利实业集团股份有限公司 乳源活性肽lppplpsrwpl及其制备方法与应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4444753C2 (de) * 1994-12-15 1998-08-06 Forssmann Wolf Georg Antibiotisch wirksame Peptide aus der bovinen Milch, deren Gewinnung und Verwendung
US6060448A (en) * 1995-10-31 2000-05-09 Pepsyn Limited Casein fragments having growth promoting activity
AUPP051497A0 (en) 1997-11-24 1997-12-18 University Of Melbourne, The Antimicrobial peptides
AU768673B2 (en) 1998-09-15 2003-12-18 Nizo Food Research Process for producing peptides from biological fluids and peptides obtainable by said process
US6514941B1 (en) 1999-12-10 2003-02-04 Campina Melkunie B.V. Method of preparing a casein hydrolysate enriched in anti-hypertensive peptides
IL134830A0 (en) * 2000-03-01 2001-05-20 Chay 13 Medical Res Group N V Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them
NZ523036A (en) 2000-05-08 2004-04-30 Davisco Foods Internat Inc Enzymatic treatment of whey proteins for the production of antihypertensive peptides, the resulting products and treatment of hypertension in mammals
GB0016189D0 (en) * 2000-06-30 2000-08-23 Pepsyn Ltd Cosmetic composition
US6465432B1 (en) 2000-08-28 2002-10-15 Kraft Food Holdings, Inc. Isolated antioxidant peptides form casein and methods for preparing, isolating, and identifying antioxidant peptides
CA2458924A1 (en) * 2001-08-30 2003-03-06 Chay 13 Medical Research Group N.V. Casein derived peptides and uses thereof in therapy
US7309491B2 (en) * 2003-04-11 2007-12-18 Antigenics Inc. Heat shock protein-based vaccines and immunotherapies
WO2004089986A1 (en) 2003-04-14 2004-10-21 Stichting Voor De Technische Wetenschappen Antimicrobial peptide from transferrin family

Also Published As

Publication number Publication date
CA2611416A1 (en) 2006-12-14
WO2006131586A1 (es) 2006-12-14
US20100048464A1 (en) 2010-02-25
ES2319475B1 (es) 2010-02-16
EP1905779A1 (en) 2008-04-02
CN101305017B (zh) 2014-08-06
KR101343904B1 (ko) 2013-12-23
AU2006256720A1 (en) 2006-12-14
EP1905779A4 (en) 2010-09-01
CN103254278B (zh) 2015-07-22
US8354502B2 (en) 2013-01-15
CN103254278A (zh) 2013-08-21
EP2495250A2 (en) 2012-09-05
WO2006131586B1 (es) 2007-02-01
EP2495250A3 (en) 2013-07-10
JP2008545774A (ja) 2008-12-18
CA2611416C (en) 2015-10-06
MX2007015528A (es) 2008-02-25
ES2319475A1 (es) 2009-05-07
KR20080045108A (ko) 2008-05-22
CN101305017A (zh) 2008-11-12
BRPI0611729A2 (pt) 2010-10-05

Similar Documents

Publication Publication Date Title
NO20080103L (no) Bioaktive peptider identifisert i encymatiske hydrolyzater av caseiner fra melk og fremgangsmater for fremskaffelse av disse
WO2007019176A3 (en) Corn protein concentrates
WO2008131008A3 (en) Protein hydrolysate compositions having improved sensory characteristics and physical properties
DK1765094T3 (da) Produkt af hydrolyseret havprotein, fremgangsmåde til dens fremstilling og anvendelse
NO20083940L (no) Fremgangsmater for redusering av proteinaggregering
MX2022008144A (es) Composiciones alimenticias con alto contenido de proteinas.
WO2011156380A3 (en) Protein-containing adhesives, and manufacture and use thereof
BR112012026906A2 (pt) método para obtenção de produtos nutritivos à base de leguminosas
DK1996028T3 (da) Faste enzymformuleringer og fremgangsmåde til deres fremstilling
MX2012001923A (es) Composicion con alto contenido proteico para la industria alimenticia.
WO2007046891A3 (en) Systems and methods for separating proteins from connective tissue
EA200800289A1 (ru) Новые ферменты для ферментативного отбеливания пищевых продуктов
MX2022010931A (es) Composiciones estructuradas analogas a la carne con alto contenido de proteinas.
Welsh et al. Comparison of bioactive peptides prepared from sheep cheese whey using a food‐grade bacterial and a fungal protease preparation
WO2005071067A3 (en) Non-animal origin stabilizers and processes for producing the same
WO2010002160A3 (ko) 돼지의 알파에스 1 카제인 유전자, 그 프로모터 및 그의 용도
WO2023012109A3 (en) Microbiota engineering
ATE493999T1 (de) Nahrungsmittel enthaltend dipeptide mit blutdrucksenkenden eigenschaften.
WO2018132821A3 (en) Elastomeric proteins
ATE472316T1 (de) Haarbehandlungszusammensetzungen
WO2006029538A8 (en) Sialyltransferases comprising conserved sequence motifs
PH12019502185A1 (en) Hydrolysed vegetable proteins suitable for use in baby food
WO2015009829A3 (en) Enhancement of osteogenic potential of bone grafts
ATE494794T1 (de) Ovo-lacto-vegetarisches nahrungsmittel oder nahrungsmittelzwischenprodukt
이지수 et al. Antioxidant and ACE inhibitory activities of soybean hydrolysates: Effect of enzyme and degree of hydrolysis

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application